Schonfeld Strategic Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-15,906
| Closed | -$508K | – | 3230 |
|
|
2022
Q2 | $508K | Sell |
15,906
-25,673
| -62% | -$820K | ﹤0.01% | 1281 |
|
|
2022
Q1 | $1.44M | Sell |
41,579
-51,961
| -56% | -$1.8M | 0.01% | 794 |
|
|
2021
Q4 | $2.74M | Buy |
93,540
+43,067
| +85% | +$1.26M | 0.02% | 567 |
|
|
2021
Q3 | $1.29M | Buy |
50,473
+30,973
| +159% | +$790K | 0.01% | 799 |
|
|
2021
Q2 | $683K | Buy |
+19,500
| New | +$683K | 0.01% | 1015 |
|
|
2021
Q1 | – | Sell |
-47,739
| Closed | -$2.07M | – | 2196 |
|
|
2020
Q4 | $2.07M | Buy |
+47,739
| New | +$2.07M | 0.03% | 561 |
|
|
2019
Q3 | – | Sell |
-128,700
| Closed | -$6.77M | – | 1300 |
|
|
2019
Q2 | $6.77M | Buy |
128,700
+55,700
| +76% | +$2.93M | 0.24% | 107 |
|
|
2019
Q1 | $3.86M | Buy |
+73,000
| New | +$3.86M | 0.13% | 206 |
|
|
2018
Q4 | – | Sell |
-11,400
| Closed | -$433K | – | 1274 |
|
|
2018
Q3 | $433K | Sell |
11,400
-66,100
| -85% | -$2.51M | 0.02% | 601 |
|
|
2018
Q2 | $3.5M | Buy |
+77,500
| New | +$3.5M | 0.19% | 183 |
|
|
2018
Q1 | – | Sell |
-22,350
| Closed | -$880K | – | 1011 |
|
|
2017
Q4 | $880K | Sell |
22,350
-50,541
| -69% | -$1.99M | 0.07% | 330 |
|
|
2017
Q3 | $2.26M | Buy |
+72,891
| New | +$2.26M | 0.21% | 141 |
|
|
2016
Q3 | – | Sell |
-77,912
| Closed | -$1.29M | – | 587 |
|
|
2016
Q2 | $1.29M | Buy |
+77,912
| New | +$1.29M | 0.29% | 94 |
|